Movement disorders and substance abuse.
Lopez
W
W
Department of Psychiatry, University of California, San Diego, USA.
Jeste
D V
DV
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects; D000437:Alcoholism / Q000150:complications; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D004347:Drug Interactions; D004409:Dyskinesia, Drug-Induced / Q000150:complications; D006801:Humans; D006816:Huntington Disease / Q000150:complications; D013287:Illicit Drugs / Q000009:adverse effects; D009069:Movement Disorders / Q000150:complications*; D019966:Substance-Related Disorders / Q000150:complications*
D000697:Central Nervous System Stimulants; D013287:Illicit Drugs; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine